Neuroleptic Malignant Syndrome
- 1 January 1987
- journal article
- research article
- Published by Taylor & Francis in The Journal of General Psychology
- Vol. 114 (1) , 39-46
- https://doi.org/10.1080/00221309.1987.9711053
Abstract
Neuroleptic Malignant Syndrome is a disabling reaction to neuroleptic drugs recently discussed in psychiatric literature in Europe, Japan, and the United States. It is rare but potentially fatal and is more likely to occur in men, especially young men, than in women. The cause is unknown, but dopamine depletion in the brain is suspected. Treatment usually begins by withdrawing the neuroleptics and then providing supportive therapy for the usual symptoms of high fever, muscular rigidity, labile blood pressure, and tachycardia. The Neuroleptic Malignant Syndrome usually lasts two to three weeks.Keywords
This publication has 34 references indexed in Scilit:
- Neuroleptic Malignant SyndromeThe British Journal of Psychiatry, 1986
- The Aftercare of the Patient with the Neuroleptic Malignant SyndromeThe British Journal of Psychiatry, 1985
- The neuroleptic malignant syndrome: Review and report of three casesComprehensive Psychiatry, 1985
- Treatment of the neuroleptic malignant syndrome with bromocriptinePublished by American Medical Association (AMA) ,1983
- Neuroleptic malignant syndrome.BMJ, 1983
- NEUROLEPTIC MALIGNANT SYNDROME AND MALIGNANT HYPERTHERMIAThe Lancet, 1983
- Treatment of neuroleptic malignant syndrome with dantrolene sodium: a case reportAmerican Journal of Psychiatry, 1982
- TREATMENT OF NEUROLEPTIC MALIGNANT SYNDROME WITH DANTROLENEThe Lancet, 1982
- Sympathoadrenomedullary hyperactivity in the neuroleptic malignant syndrome: a case reportAmerican Journal of Psychiatry, 1981
- Malignant neuroleptic syndrome: An atypical casePsychosomatics, 1979